These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 6320334)

  • 1. [Possibilities and prospects of immunoprophylaxis and immunotherapy of pyocyanic infections under supervision of these infections using epidemiological markers].
    Meitert E; Meitert T
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(4):289-302. PubMed ID: 6320334
    [No Abstract]   [Full Text] [Related]  

  • 2. An outbreak of imipenem-resistant Pseudomonas aeruginosa in an intensive care unit.
    Majumdar S; Kirby A; Berry N; Williams C; Hassan I; Eddleston J; Burnie JP
    J Hosp Infect; 2004 Oct; 58(2):160-1. PubMed ID: 15474190
    [No Abstract]   [Full Text] [Related]  

  • 3. [A program for prevention of pseudomonas infections and immunoprophylaxis with PSAEVA vaccine].
    Kahlich R; Vojtísková J; Táborský J; Sedlácková E; Liska M; Pechancová J; Totusek P
    Cesk Epidemiol Mikrobiol Imunol; 1992 Sep; 42(3):120-5. PubMed ID: 1339603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pseudomonas pyocyanea infections in otorhinolaryngology].
    Nicoucar GR
    Pract Otorhinolaryngol (Basel); 1969; 31(6):359-64. PubMed ID: 4314671
    [No Abstract]   [Full Text] [Related]  

  • 5. [Proceedings: Prevention of the Pyocyaneus infections].
    Tanner F; Schäfer H; Jekić M; Andrasina J
    Hefte Unfallheilkd; 1973; 114():127-33. PubMed ID: 4205707
    [No Abstract]   [Full Text] [Related]  

  • 6. Need for both antibiotic cycling and stringent environmental controls to prevent Pseudomonas infections.
    Curtis L
    Surg Infect (Larchmt); 2009 Apr; 10(2):163. PubMed ID: 19388838
    [No Abstract]   [Full Text] [Related]  

  • 7. [Hospital contamination by the pyocyanic bacillus in obstetrics and gynecology. Methods of controlling and preventing it].
    Brunet C; Dumont M
    Rev Fr Gynecol Obstet; 1970 Nov; 65(11):661-4. PubMed ID: 4991938
    [No Abstract]   [Full Text] [Related]  

  • 8. Control of Pseudomonas aeruginosa infections.
    Klastersky J
    Acta Clin Belg; 1974; 29(4):233-9. PubMed ID: 4215269
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of Pseudomonas aeruginosa infection.
    Eykyn SJ
    Br J Hosp Med; 1984 Feb; 31(2):136-40. PubMed ID: 6421353
    [No Abstract]   [Full Text] [Related]  

  • 10. [Pyocyanic infection in burned patients. Immunitary protection].
    Moyen EN; Lesage D; Romano P
    Nouv Presse Med; 1972 Apr; 1(14):947-50. PubMed ID: 4623061
    [No Abstract]   [Full Text] [Related]  

  • 11. [Pyocyanic infections in the newborn].
    Gobio Casali L; Fornasini F
    Minerva Pediatr; 1976 Nov; 28(36):2211-24. PubMed ID: 825716
    [No Abstract]   [Full Text] [Related]  

  • 12. [Modern aspects of the treatment of Pseudomonas aeruginosa infection].
    Rozhavin MA
    Antibiotiki; 1980 Apr; 25(4):303-7. PubMed ID: 6768339
    [No Abstract]   [Full Text] [Related]  

  • 13. Should we be afraid of the Green Monster?
    Rumbaugh K
    Crit Care Med; 2009 May; 37(5):1826-7. PubMed ID: 19373066
    [No Abstract]   [Full Text] [Related]  

  • 14. Usefulness of a computerized expert system associated with systematic O-serotyping for the early detection of outbreaks of hospital acquired infections and for the presumptive antibiotic therapy of Pseudomonas aeruginosa infections.
    Watine J; Charet JC; Bruel A; Bouilloux JP; Palliez J
    Pathol Biol (Paris); 1996 Feb; 44(2):125-31. PubMed ID: 8761597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Current therapies for pseudomonas aeruginosa.
    Giamarellou H; Kanellakopoulou K
    Crit Care Clin; 2008 Apr; 24(2):261-78, viii. PubMed ID: 18361945
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic bronchopulmonary infections].
    Popescu C; Meitert E; Russ R; Meitert T; Sima F; Savulian C; Esrig E
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1983; 32(3):261-72. PubMed ID: 6318298
    [No Abstract]   [Full Text] [Related]  

  • 17. Treatment of multidrug-resistant Pseudomonas aeruginosa infections: more attention required to in-vitro studies.
    Zavascki AP
    Clin Microbiol Infect; 2005 Oct; 11(10):856-7. PubMed ID: 16153266
    [No Abstract]   [Full Text] [Related]  

  • 18. Epidemiological and immunobiological implications of Pseudomonas aeruginosa epidemiological markers.
    Meitert T; Meitert E
    Arch Roum Pathol Exp Microbiol; 1981; 40(1):5-23. PubMed ID: 6821022
    [No Abstract]   [Full Text] [Related]  

  • 19. Immunotherapy with monovalent Pseudomonas aeruginosa vaccine in chronic respiratory infections.
    Popescu C; Meitert E; Rusu R; Meitert T; Sima F; Savulian C
    Arch Roum Pathol Exp Microbiol; 1982; 41(3):265-76. PubMed ID: 6818929
    [No Abstract]   [Full Text] [Related]  

  • 20. Risk factors for imipenem-resistant Pseudomonas aeruginosa: a comparative analysis of two case-control studies in hospitalized patients.
    Zavascki AP; Cruz RP; Goldani LZ
    J Hosp Infect; 2005 Feb; 59(2):96-101. PubMed ID: 15620442
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.